Company profile TCRX
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. TScan Therapeutics expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 74 | 182 145.9% QoQ | 351 92.9% QoQ | 291 -17.1% QoQ |
| 2020 | 72 -2.7% YoY -75.3% QoQ | 139 -23.6% YoY 93.1% QoQ | 195 -44.4% YoY 40.3% QoQ | 37 -87.3% YoY -81.0% QoQ |
| 2021 | 86 19.4% YoY 132.4% QoQ | 196 41.0% YoY 127.9% QoQ | 351 80.0% YoY 79.1% QoQ | 188 408.1% YoY -46.4% QoQ |
| 2022 | 59 -31.4% YoY -68.6% QoQ | 310 58.2% YoY 425.4% QoQ | 166 -52.7% YoY -46.5% QoQ | 68 -63.8% YoY -59.0% QoQ |
| 2023 | 255 332.2% YoY 275.0% QoQ | 205 -33.9% YoY -19.6% QoQ | 197 18.7% YoY -3.9% QoQ | 226 232.4% YoY 14.7% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of TScan Therapeutics was 13.98 per week. The last year interest of TScan Therapeutics compared to the last 5 years has changed by 11.3%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by -9.9%.
There is not enough data for T cell receptor-engineered T cell therapies to provide analysis
There is not enough data for T cell receptor-engineered T cell therapies to provide correlation calculation
There is not enough data for T cell receptor-engineered T cell therapies to provide analysis
There is not enough data for clinical-stage biopharmaceutical company to provide analysis
There is not enough data for clinical-stage biopharmaceutical company to provide correlation calculation
There is not enough data for clinical-stage biopharmaceutical company to provide analysis
After 39 days of this quarter the interest is at 110.0. Based on that we can calculate that during remaining 52 days it will total up to 257.0. hematologic malignancies expected interest is significantly lower compared to previous quarter (-50.6%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 288 | 443 53.8% QoQ | 354 -20.1% QoQ | 268 -24.3% QoQ |
| 2020 | 469 62.8% YoY 75.0% QoQ | 212 -52.1% YoY -54.8% QoQ | 288 -18.6% YoY 35.8% QoQ | 177 -34.0% YoY -38.5% QoQ |
| 2021 | 254 -45.8% YoY 43.5% QoQ | 411 93.9% YoY 61.8% QoQ | 562 95.1% YoY 36.7% QoQ | 495 179.7% YoY -11.9% QoQ |
| 2022 | 527 107.5% YoY 6.5% QoQ | 297 -27.7% YoY -43.6% QoQ | 315 -44.0% YoY 6.1% QoQ | 511 3.2% YoY 62.2% QoQ |
| 2023 | 413 -21.6% YoY -19.2% QoQ | 274 -7.7% YoY -33.7% QoQ | 434 37.8% YoY 58.4% QoQ | 520 1.8% YoY 19.8% QoQ |
| 2024 | 110 -73.4% YoY -78.8% QoQ | - | - | - |
The average 5 years interest of hematologic malignancies was 29.2 per week. The last year interest of hematologic malignancies compared to the last 5 years has changed by 0.89%. The interest for hematologic malignancies is seasonal. The last year interest is comparable to 5 years ago. It has changed only by 0.65%.
After 39 days of this quarter the interest is at 312.0. Based on that we can calculate that during remaining 52 days it will total up to 728.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 590 | 845 43.2% QoQ | 776 -8.2% QoQ | 794 2.3% QoQ |
| 2020 | 821 39.2% YoY 3.4% QoQ | 721 -14.7% YoY -12.2% QoQ | 697 -10.2% YoY -3.3% QoQ | 687 -13.5% YoY -1.4% QoQ |
| 2021 | 724 -11.8% YoY 5.4% QoQ | 766 6.2% YoY 5.8% QoQ | 750 7.6% YoY -2.1% QoQ | 691 0.6% YoY -7.9% QoQ |
| 2022 | 874 20.7% YoY 26.5% QoQ | 849 10.8% YoY -2.9% QoQ | 735 -2.0% YoY -13.4% QoQ | 817 18.2% YoY 11.2% QoQ |
| 2023 | 870 -0.5% YoY 6.5% QoQ | 866 2.0% YoY -0.5% QoQ | 847 15.2% YoY -2.2% QoQ | 934 14.3% YoY 10.3% QoQ |
| 2024 | 312 -64.1% YoY -66.6% QoQ | - | - | - |
The average 5 years interest of leukemia treatment was 61.17 per week. The last year interest of leukemia treatment compared to the last 5 years has changed by 9.02%. The interest for leukemia treatment is relatively stable in the last 5 years. The last year interest is comparable to 5 years ago. It has changed only by 4.17%.
After 39 days of this quarter the interest is at 276.0. Based on that we can calculate that during remaining 52 days it will total up to 644.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 516 | 815 57.9% QoQ | 830 1.8% QoQ | 799 -3.7% QoQ |
| 2020 | 785 52.1% YoY -1.8% QoQ | 903 10.8% YoY 15.0% QoQ | 847 2.0% YoY -6.2% QoQ | 873 9.3% YoY 3.1% QoQ |
| 2021 | 788 0.4% YoY -9.7% QoQ | 847 -6.2% YoY 7.5% QoQ | 785 -7.3% YoY -7.3% QoQ | 808 -7.4% YoY 2.9% QoQ |
| 2022 | 905 14.8% YoY 12.0% QoQ | 910 7.4% YoY 0.6% QoQ | 878 11.8% YoY -3.5% QoQ | 880 8.9% YoY 0.2% QoQ |
| 2023 | 805 -11.0% YoY -8.5% QoQ | 845 -7.1% YoY 5.0% QoQ | 749 -14.7% YoY -11.4% QoQ | 989 12.4% YoY 32.0% QoQ |
| 2024 | 276 -65.7% YoY -72.1% QoQ | - | - | - |
The average 5 years interest of relapse prevention was 64.49 per week. The last year interest of relapse prevention compared to the last 5 years has changed by -1.09%. The interest for relapse prevention is relatively stable in the last 5 years. The last year interest is comparable to 5 years ago. It has changed only by 1.69%.
After 39 days of this quarter the interest is at 93.0. Based on that we can calculate that during remaining 52 days it will total up to 217.0. hematopoietic stem cell transplantation expected interest is significantly lower compared to previous quarter (-52.2%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 174 | 468 169.0% QoQ | 415 -11.3% QoQ | 352 -15.2% QoQ |
| 2020 | 406 133.3% YoY 15.3% QoQ | 300 -35.9% YoY -26.1% QoQ | 202 -51.3% YoY -32.7% QoQ | 293 -16.8% YoY 45.0% QoQ |
| 2021 | 290 -28.6% YoY -1.0% QoQ | 188 -37.3% YoY -35.2% QoQ | 261 29.2% YoY 38.8% QoQ | 283 -3.4% YoY 8.4% QoQ |
| 2022 | 447 54.1% YoY 58.0% QoQ | 414 120.2% YoY -7.4% QoQ | 200 -23.4% YoY -51.7% QoQ | 193 -31.8% YoY -3.5% QoQ |
| 2023 | 275 -38.5% YoY 42.5% QoQ | 395 -4.6% YoY 43.6% QoQ | 241 20.5% YoY -39.0% QoQ | 454 135.2% YoY 88.4% QoQ |
| 2024 | 93 -66.2% YoY -79.5% QoQ | - | - | - |
The average 5 years interest of hematopoietic stem cell transplantation was 24.31 per week. The last year interest of hematopoietic stem cell transplantation compared to the last 5 years has changed by 10.9%. The interest for hematopoietic stem cell transplantation is seasonal. The last year interest is comparable to 5 years ago. It has changed only by -12.21%.
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. solid tumors treatment expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 29 | 211 627.6% QoQ | 223 5.7% QoQ | 124 -44.4% QoQ |
| 2020 | 15 -48.3% YoY -87.9% QoQ | 186 -11.8% YoY 1140.0% QoQ | 59 -73.5% YoY -68.3% QoQ | 96 -22.6% YoY 62.7% QoQ |
| 2021 | 95 533.3% YoY -1.0% QoQ | 89 -52.2% YoY -6.3% QoQ | 172 191.5% YoY 93.3% QoQ | 152 58.3% YoY -11.6% QoQ |
| 2022 | 117 23.2% YoY -23.0% QoQ | 153 71.9% YoY 30.8% QoQ | 99 -42.4% YoY -35.3% QoQ | 188 23.7% YoY 89.9% QoQ |
| 2023 | 70 -40.2% YoY -62.8% QoQ | 113 -26.1% YoY 61.4% QoQ | 86 -13.1% YoY -23.9% QoQ | 182 -3.2% YoY 111.6% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of solid tumors treatment was 9.42 per week. The last year interest of solid tumors treatment compared to the last 5 years has changed by -22.19%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -35.08%.
After 39 days of this quarter the interest is at 231.0. Based on that we can calculate that during remaining 52 days it will total up to 539.0. vaccines for infectious diseases expected interest is significantly higher compared to previous quarter (+119.1%) and same quarter last year (+239.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 42 | 63 50.0% QoQ | 83 31.7% QoQ | 197 137.3% QoQ |
| 2020 | 113 169.0% YoY -42.6% QoQ | 291 361.9% YoY 157.5% QoQ | 151 81.9% YoY -48.1% QoQ | 313 58.9% YoY 107.3% QoQ |
| 2021 | 227 100.9% YoY -27.5% QoQ | 170 -41.6% YoY -25.1% QoQ | 306 102.6% YoY 80.0% QoQ | 74 -76.4% YoY -75.8% QoQ |
| 2022 | 219 -3.5% YoY 195.9% QoQ | 135 -20.6% YoY -38.4% QoQ | 90 -70.6% YoY -33.3% QoQ | 259 250.0% YoY 187.8% QoQ |
| 2023 | 159 -27.4% YoY -38.6% QoQ | 343 154.1% YoY 115.7% QoQ | 233 158.9% YoY -32.1% QoQ | 246 -5.0% YoY 5.6% QoQ |
| 2024 | 231 45.3% YoY -6.1% QoQ | - | - | - |
The average 5 years interest of vaccines for infectious diseases was 15.11 per week. The last year interest of vaccines for infectious diseases compared to the last 5 years has changed by 54.27%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 194.32%.
There is not enough data for Novartis collaboration to provide analysis
There is not enough data for Novartis collaboration to provide correlation calculation
There is not enough data for Novartis collaboration to provide analysis
There is not enough data for Amgen collaboration to provide analysis
There is not enough data for Amgen collaboration to provide correlation calculation
There is not enough data for Amgen collaboration to provide analysis